News
Save the date SNMMI 2026 Annual Meeting May 30-June 2nd
Annual Meeting held in Los Angeles this year
177Lu PSMA MSAC Public Summary Document
MSAC released a Public Summary Document regarding the Application No 1686.1 - 177Lutetium PSMA i&t for metastatic castrate resistant prostate cancer regarding advice to the minister that it supports the creation of an MBS item descriptor agnostic tot he type of 177Lu PSMA therapy.